Frequently Asked Questions

Yes. Sharps Medical Waste Services reviews and acts on client and staff suggestions and uses it to keep improving how we deliver services and run our operations.

Sharps Medical Waste Services runs the facilities and trucks needed to reliably collect and process medical waste across its network. All operations follow federal, state, and local rules to ensure waste is handled safely and correctly.

Sharps Medical Waste Services supports healthcare organizations of all sizes, from large acute care facilities to single physician offices. Our services address the medical waste streams commonly generated by healthcare facilities, including regulated medical waste, sharps waste, pharmaceutical waste, DEA controlled substances, chemotherapy waste, and hazardous waste. We also support with other waste needs, like secure document shredding and full waste-management programs that meet operational and compliance requirements.

Sharps Medical Waste Services participates in GPO relationships. Contract participation and availability may vary; customers should contact Sharps directly for current contract details and eligibility. Alliant, HealthTrust, Magnet Group, Premier, Sevaredent, Vizient, WellLink, Louisiana Dental Association, Louisiana Hospital Association – Sharecor, and more.

Due to the variable nature of Sharps Medical Waste Services, pricing is not typically listed directly within GPO contracts. Pricing depends on several factors, including the number of containers and accessories, waste volumes and types, container processing requirements, the service levels provided, and the transportation frequency and distance.

Sharps Medical Waste Services is contracted to handle all waste streams generated by all members of the GPOs we have contracted with.

A group purchasing organization (GPO) brings businesses together to combine their buying power to secure lower prices on products and services. Effective purchasing management is essential for smooth operations, high-quality service, and meaningful cost savings.

Designed as a full-solution medical waste system, the Sharps MWS containers delivers cost efficiencies across consumables, labor, and waste segregation. The clinical appearance of the Sharps MWS container discourages staff and patients from using it for general waste disposal. The resulting reduction in medical waste volumes can significantly lower costs. Its compact design and transportation accessories also help reduce the workload of environmental services staff.

The Sharps MWS medical waste container system actively supports infection risk reduction and improved medical waste segregation. A peer-reviewed study conducted in a Sydney-based hospital demonstrated medical waste mass reduction of 53.2% and volume reduction of 65.2%. Additional details are available within case study materials.

Each year, for every 100 occupied beds, reusable sharps containers eliminate the manufacturing and landfilling of approximately 4,691 disposable sharps containers.

Hospitals converting from disposable sharps containers to reusable sharps disposal containers can reduce, on average, plastic waste by 3.5 tons and cardboard waste by 0.4 tons per 100 occupied beds per year.

Each year in the United States alone, reusable sharps disposal containers eliminate approximately 2,072,300 pounds of disposable sharps containers from landfills. This is equivalent to the weight of nearly three Airbus A380 aircraft or approximately 3,500 male grizzly bears.

The compact design of Sharps MWS medical waste container allows placement at the point of which waste is generated, eliminating the need to transfer waste into larger tubs after disposal.

The TakeAway Recovery System for Trace Chemo container system is designed for transport durability and includes integrated safety mechanisms intended to protect staff during use. Compared to disposable chemotherapy containers, which typically involve a multi-step process including purchase, assembly, bagging, boxing, double packaging, and transport, our containers simplify handling into three primary steps: moving the container to the point of waste generation, disposal, and securing the container for transport.

Medical waste management cost efficiencies are achieved through successful deployment. Sharps Medical Waste Services works closely with customers to help ensure healthcare staff are protected, trained, and properly equipped; that medical waste and sharps disposal containers support safety, segregation, and usability; and that facility risk profiles are effectively managed. Together, these elements contribute to meaningful reductions in overall waste management costs.

Designed as a full-solution medical waste system, the Sharps MWS containers delivers cost efficiencies across consumables, labor, and segregation. The clinical appearance of the container discourages misuse for general waste disposal, helping reduce medical waste volumes and associated costs. Its compact design and transportation accessories also reduce the workload of environmental services staff.

Glass capable of puncturing skin is considered a sharp and must be disposed of in an approved sharps container.

No. All healthcare waste must be managed in accordance with the Bloodborne Pathogens Standard. Facilities must assess workplace risks and document procedures that reduce or eliminate employee contact with blood or other potentially infectious materials (OPIM).

All RMW bins or cardboard boxes require an inner liner (film bag) to meet regulatory packaging requirements under 49 CFR 173.197(e).

Diapers, human feces, and urine are not considered biohazardous waste unless visibly contaminated with blood. In most cases, these items may be disposed of as regular waste.

Sharps Medical Waste Services supports a range of healthcare waste streams, including sharps, regulated medical waste (RMW/biohazard), trace chemotherapy, non-hazardous pharmaceuticals, pathological waste, and hazardous/RCRA waste.

No. Waste containers are provided as part of your service. Containers are installed on-site and exchanged based on your service schedule—ranging from multiple times per week to less frequent intervals. Full containers are replaced with clean, sanitized ones, helping maintain a safe and compliant environment.

Monkeypox is classified into two clades: West African and Central African (Congo Basin). The West African clade is generally less severe and associated with lower rates of human-to-human transmission compared to the Congo Basin clade.

Storage and removal timelines for regulated medical waste vary by jurisdiction. Requirements may differ based on location, waste volume, and generator classification (e.g., large-quantity or small-quantity generator). Storage temperature rules may also apply. Given these variations, it’s important to to work with a vendor that can provide clarity for all waste streams.

Handling requirements depend on the identified clade. Waste from the West African clade is managed as routine regulated medical waste (UN 3291) and packaged according to standard regulations. Waste from the Congo Basin clade must be handled as a Category A infectious substance (UN 2814), with packaging and transport requirements determined by regulatory authorities and, in some cases, requiring special permits. Category A monkeypox waste is regulated by USDOT and may require a special permit (SP) for transport. If you determine epidemiologically or through clade identification that a patient has the Congo Basin clade, please contact your Sharps Medical Waste Services representative for guidance on sharps waste handling, including Category A packaging and transport requirements.

Regulated medical waste is classified under Packaging Group II (PG II), with the proper shipping name Regulated Medical Waste, n.o.s., within Hazard Class 6, Division 6.2. A Division 6.2 infectious substance, including regulated medical waste, is considered a hazardous material and is therefore subject to the Hazardous Materials Regulations (HMR). Because it falls under these regulations, anyone involved in handling or transporting this waste is considered a HazMat employee and must complete the required training.

Regulated medical waste includes blood and other potentially infectious materials generated in healthcare settings such as hospitals, clinics, physician offices, and other care facilities.

Common subtypes of regulated medical waste include pathological waste such as tissues, organs, body parts, and body fluids removed during surgery or autopsy; human blood and blood products like serum, plasma, and other components; microbiological waste including cultures, stocks of infectious agents, laboratory specimens, culture dishes, and discarded vaccines; contaminated sharps such as needles, syringes, scalpel blades, pipettes, and broken glass capable of puncturing the skin; isolation waste generated from patients placed under isolation for communicable diseases; contaminated animal waste including carcasses, body parts, and bedding from animals intentionally exposed to pathogens in research or drug testing; trace chemotherapy waste containing residual amounts of antineoplastic drugs in items like vials, tubing, IV bags, and PPE; and non-hazardous pharmaceutical waste, which is not regulated under RCRA but still requires proper controlled disposal.

Biomedical (biohazardous) waste is regulated through a combination of federal and state laws, with the Medical Waste Tracking Act (MWTA) serving as one of the foundational frameworks. Enacted in the 1980s, the MWTA helped define which waste types must be regulated and established requirements for segregation, packaging, and storage. It also introduced a beginning to end tracking system and set penalties for improper handling. Under cradle-to-grave responsibility, healthcare facilities remain accountable for their waste from the moment it is generated through final treatment and disposal, even after it has been collected by a licensed medical waste service provider. Any claim that liability is transferred or waived is incorrect, as this is not permitted under federal law. Storage requirements vary by state, so facilities must follow the regulations that apply to their specific location. A waste manifest is required at the time of pickup, and anyone signing it must be properly trained and certified under applicable DOT regulations. Common regulatory requirements include limits on how long medical waste may be stored, maintaining separation between clean and used containers, and ensuring that storage areas for used containers are secured.

Medical waste handling and disposal are governed by both federal and state regulations. Requirements for storage, handling, and transport can vary depending on your location and the type and volume of waste generated. To ensure compliance, refer to your state’s regulatory authority or applicable federal guidelines found here: [INSERT LINK].

Biomedical waste, also referred to as regulated medical waste, red bag waste, or biohazardous waste, includes any solid or liquid waste contaminated with blood, human body fluids, or other materials capable of transmitting infection. This category of waste can include anatomical materials, sharps, and laboratory waste, all of which require proper segregation to reduce exposure risks. The Centers for Disease Control and Prevention defines medical waste as “waste sufficiently capable of causing infection during its handling and disposal,” underscoring the importance of correct containment and management. Sharps Medical Waste Services provides compliant disposal containers designed for the waste types commonly generated in healthcare settings, including regulated medical waste, sharps, pharmaceuticals, chemotherapy waste, and other related materials that require controlled handling.

Medical waste containers should never be overfilled or compressed. Once waste reaches the designated fill line, the container should be securely closed and prepared for service. Overfilling increases risk of injury or exposure.

Regulated Medical Waste (RMW) is classified under Hazard Class 6, Division 6.2 in accordance with the Hazardous Materials Regulations (HMR) established by PHMSA/USDOT.

Typical regulated medical waste includes items such as blood‑soaked gauze or bandages, PPE contaminated with blood or body fluids, and plastic tubing containing biological contamination. Materials like medications, loose sharps, chemotherapy waste, pharmaceuticals, and hazardous waste must not be placed in regulated medical waste containers, as they require separate handling and disposal pathways.

A biohazard is biological material that poses a potential risk to human health, animals, or the environment, as defined under OSHA regulation 29 CFR 1910.1030.

A generator is any individual (including doctors and nurses) or organization (such as a dentist, veterinarian practice or hospital) whose activities produce medical waste, including healthcare providers, laboratories, pharmacies, veterinary practices, and similar facilities.

Infectious waste, also referred to as biohazardous or biomedical waste, includes any material containing infectious agents or potentially infectious substances such as blood or bodily fluids generated during patient care. Sharps that have come into direct contact with a patient, including needles, blades, and lancets, are considered biohazardous and must be placed in a compliant, clinical-grade sharps container to reduce the risk of exposure and injury.

Medical waste refers to solid waste generated during the diagnosis, treatment, or immunization of humans or animals, as well as in research or the production and testing of biological materials. Medical waste disposal generally refers to the collection, transport, and treatment of this waste by a licensed provider. It does not include hazardous or radioactive waste.

Regulated medical waste, often referred to as red bag waste or biohazardous waste, is defined as waste contaminated with blood, body fluids, or other potentially infectious materials that may pose a risk of transmitting infection. According to the Centers for Disease Control and Prevention, medical waste is “waste sufficiently capable of causing infection during handling and disposal,” underscoring the need for proper containment and management. Sharps Medical Waste Services provides compliant disposal containers designed for the waste streams commonly generated in healthcare settings, including regulated medical waste, sharps waste, pharmaceutical waste, chemotherapy waste, and other materials that require controlled handling.

Biological waste, often referred to as regulated medical waste, biohazardous waste, or medical waste, is any material contaminated with blood or other potentially infectious substances. Because this type of waste can carry a risk of infection, it must be properly treated, typically through sterilization methods such as high-heat autoclaving before final disposal. Regular trash does not require sterilization and is generally sent directly to landfill. Items like feces, urine, and adhesive bandages are often mistaken for biological waste; however, if they are not infectious, they may be disposed of as regular waste.

Biomedical waste disposal guidelines are regulated through a combination of federal and state laws that address labeling, containment, storage, transportation, and treatment. The Environmental Protection Agency (EPA) and state health departments oversee treatment facilities to ensure proper processing and environmental safety, while OSHA, the Department of Transportation (DOT), and the Centers for Disease Control and Prevention (CDC) establish standards for labeling, containment, and the safe management of medical waste and sharps disposal containers. Together, these agencies define the compliance framework that healthcare facilities must follow to handle biomedical waste responsibly.

Medical waste disposal is regulated at both the federal and state levels, with requirements governing labeling, containment, storage, transport, and treatment. The Environmental Protection Agency (EPA) and state health departments oversee treatment facilities to ensure environmental protection and proper processing. OSHA, the Department of Transportation (DOT), and the Centers for Disease Control and Prevention (CDC) establish standards for labeling, containment, classification, and the safe handling of medical waste and sharps disposal containers. These agencies collectively define the compliance framework that healthcare facilities must follow to manage medical waste safely and responsibly.

Yes. Chemotherapy containers that meet DOT requirements and carry a PG 2 rating can be used without secondary packaging. These containers are designed with features such as a gasketed, locking, leak-resistant seal, allowing them to be transported without the additional bagging or secondary packaging required for many disposable or other reusable chemotherapy containers.

The appropriate container color for chemotherapy waste depends on whether the material is classified as trace or bulk chemotherapy waste. Trace amounts, defined as less than 3% of the original volume, should be placed in a yellow chemotherapy container that is properly labeled and approved for chemotherapy waste collection. Bulk chemotherapy waste, including partially full IV bags, vials, or syringes, must be disposed of in a black RCRA hazardous waste container, as it contains higher concentrations of chemotherapy drugs and requires more stringent handling.

Bulk chemotherapy waste is classified as RCRA hazardous waste and refers to any chemotherapy drug with more than 3% of the original volume remaining. Because of its concentration, all bulk chemotherapy waste must be managed as RCRA hazardous waste and collected in a properly designated RCRA chemotherapy waste container or bin. It is a violation of Dangerous Waste Regulations to dispose of these materials in the sewer, in a sharps container, or in a regulated medical waste container.

Regulations require that chemotherapy waste be treated through incineration. Approved containers and liners must be used for safe handling, transport, and final disposal.

Sharps Medical Waste Services offers chemotherapy waste solutions such as the 20-Gallon TakeAway Recovery System for Trace Chemo, which is designed for regulatory-compliant containment, transport, and treatment of needles, empty vials and syringes, and other items contaminated with trace amounts of chemotherapy or other cytotoxic drugs or chemicals. This leak-resistant system accommodates smaller existing sharps containers (no loose sharps) and includes a 20-gallon collection container, prepaid return packaging, return transportation, and proper treatment of the contents. Each system is uniquely serialized for tracking and provides documented proof of treatment, supporting healthcare facilities in meeting their chemotherapy waste management and compliance obligations

Bulk chemotherapy waste is defined as chemotherapy material that contains more than 3% of the original volume and is therefore classified as RCRA hazardous waste. Full or partially full IV bags, bottles, vials, and tubing, as well as P-listed chemotherapy drugs, must be managed under hazardous waste regulations and cannot be placed in trace chemotherapy containers. Bulk chemotherapy waste includes any non-empty containers that once held chemotherapy agents, materials designated as RCRA hazardous or state-only dangerous waste, all containers or IV components that previously contained a P-listed substance such as arsenic trioxide, and any materials used to clean up a chemotherapy spill. These items must be collected and disposed of in a properly designated hazardous waste container to ensure compliance and safe handling.

Chemotherapy waste is classified by the EPA as a hazardous chemical waste and is generated from the preparation or administration of chemotherapy drugs. It is typically divided into two categories, trace and bulk chemotherapy waste, based on the amount of residual drug present. Depending on this classification, chemotherapy waste must be placed in either a designated trace chemotherapy container or a hazardous waste container to ensure proper handling, transport, and treatment in accordance with regulatory requirements.

Trace chemotherapy waste refers to vials, IV bags, tubing, and other containers that hold less than 3% of their original chemotherapy contents after normal emptying. These materials may exhibit characteristics such as toxicity, reactivity, ignitability, or corrosivity, and must be managed separately from bulk chemotherapy waste. Trace chemotherapy waste includes empty chemotherapy containers, IV bags or bottles, IV tubing that did not contain a P-listed or state-only hazardous waste, as well as empty vials, needles, gloves, gowns, masks, and other PPE used during chemotherapy preparation or infusion that are not visibly contaminated. These items can be placed in a designated trace chemotherapy container to ensure compliant handling and disposal.

Pharmaceutical waste that falls under the Resource Conservation and Recovery Act (RCRA) of 1976, as amended (42 USCA Sec. 6901 et seq.) must be disposed of in an approved hazardous waste container. These materials require controlled handling to ensure compliance with federal and state regulations.

If a lidocaine formulation has a pH of 2 or below, it is considered a RCRA hazardous waste for corrosivity (waste code D002). These materials must be disposed of in an approved hazardous waste container.

Hazardous characteristic wastes are materials that are not specifically listed by the EPA but exhibit one or more hazardous properties. These include ignitability, where a waste can readily catch fire; corrosivity, where a waste is strongly acidic or alkaline; reactivity, where a waste may explode, react violently, or release toxic gases; and toxicity, where a waste may leach harmful concentrations of chemicals into groundwater. Any waste exhibiting one or more of these characteristics must be disposed of in an approved hazardous waste container.

Listed wastes are materials the EPA has formally identified as hazardous. P-listed wastes are acutely toxic and include certain pharmaceuticals and chemicals used in healthcare settings, such as acetamide, epinephrine, nicotine and salts, and warfarin at concentrations above 0.3%. U-listed wastes are toxic commercial chemical products, including substances such as triallate, ethanamine, acetyl chloride, and warfarin at concentrations of 0.3% or less. All listed wastes must be disposed of in an approved hazardous waste container to ensure proper handling and regulatory compliance.

Pharmaceuticals become Resource Conservation and Recovery Act (RCRA) hazardous waste when they are no longer usable, such as expired, damaged, or returned medications. Their classification determines storage limits, generator status, and packaging requirements. All RCRA hazardous pharmaceuticals must be disposed of in an approved hazardous waste container.

U‑listed drugs include certain pharmaceuticals commonly found in healthcare environments, such as nicotine, warfarin, lindane, and cyclophosphamide. These materials fall under RCRA hazardous waste regulations and must be disposed of in an approved hazardous waste container.

Hazardous waste includes any discarded material that poses a potential risk to human health or the environment. The EPA identifies hazardous waste through specific listings and through characteristics such as ignitability, corrosivity, reactivity, and toxicity. Examples include expired pharmaceuticals or items containing mercury. These wastes must always be disposed of in an approved hazardous waste container.

Hazardous waste transporters and any employees responsible for signing manifests must complete DOT-required hazardous materials training. Sharps Medical Waste Services online module takes approximately 4 hours to complete and is required to be taken within 90 days of initial hire and once every 3 years. This training ensures staff understand proper handling, documentation, and transport requirements for hazardous waste.

The Environmental Protection Agency (EPA) actively enforces Resource Conservation and Recovery Act (RCRA) hazardous waste regulations. Improper disposal can result in significant penalties, including corporate fines (up to $37,500) assessed per violation per day, as well as potential personal liability for involved employees including the CEO.

Yes, radioactive sharps may be placed in a sharps container provided two conditions are met. First, the radioactive material must decay to below the state-defined threshold for safe disposal before the container leaves the healthcare facility. Second, the container must be stored in the facility’s required lead-lined enclosure until the radioactivity has diminished to an approved level. Once these conditions are met, the sharps container can be managed through the facility’s standard disposal process.

While regulated medical waste is often treated through autoclaving, many states require pathological waste to be processed by incineration. Incineration uses high heat to reduce the material to ash and is mandated in jurisdictions where this method is required for compliance. Sharps Medical Waste Services follows the treatment standards established by each state to ensure the proper handling and disposal of pathological waste.

Pathological waste includes human or animal body parts such as organs, tissues, surgical specimens, and bodily fluids removed during surgery or autopsy. This type of waste must be placed in an approved pathological waste container to ensure safe handling and compliant disposal in accordance with state and federal regulations.

Yes. According to 21 CFR 1300.05, a controlled substance is considered destroyed on-site when destruction occurs at the physical premises of the registrant’s registered location. A hospital or clinic is considered to have an on-site pharmacy when the pharmacy is located within the registered premises.

Registrants must complete a disposal log (DEA Form 41) and maintain records onsite for a minimum of two years when disposing of expired or unused controlled substances. State boards of pharmacy may impose additional local or state requirements that must also be followed.

Yes. The activated carbon and solution used in these products are non-corrosive and non-toxic to skin and eyes. The carbon is non-flammable and stable under normal conditions. No harmful effects are known to be associated with ingestion of carbon.

If ingestion occurs, contact Poison Control at (800) 222-1222.

Yes the Pharmaceutical Waste Stream includes residual medicines which may be contained in partly emptied glass vials, hard capsule or tablet medication, broken ampoules and drawing up needles. These wastes should always be disposed in an approved pharmaceutical waste container.

The DEA requires that any destruction method render a controlled substance non-retrievable, meaning it can no longer be used or recovered. Testing has demonstrated that Secure a Drug and Rx Destroyer meet this requirement. Ultimately, the waste generator is responsible for ensuring compliance with all facility, local, state, tribal, and federal regulations.

No. While these solutions may meet DEA requirements for controlled substance disposal, they do not change the hazardous characteristics of substances regulated under RCRA. RCRA hazardous waste remains hazardous after being rendered non-retrievable and must be managed accordingly.

Pharmaceutical waste regulated under the Resource Conservation and Recovery Act (RCRA) of 1976 (42 USCA Sec. 6901 et seq.) must be disposed of in an approved hazardous waste container.

Approximately 5% of an average drug inventory is considered hazardous waste by the EPA. These pharmaceuticals must be handled, transported, and disposed of as hazardous waste and placed in approved hazardous waste containers. Facilities are responsible for maintaining accurate classification and ensuring compliance with EPA and DOT regulations.

The DEA defines non-retrievable as a condition in which a controlled substance has been permanently altered through irreversible means so that it is unavailable and unusable for all practical purposes (21 CFR 1300.05). In practical terms, controlled substances must be transformed so they cannot be diverted for illicit use.

The U.S. Drug Enforcement Administration regulates controlled substance disposal under Title 21 Part 1317 of the Code of Federal Regulations. Requirements apply to both DEA registrants and non-registrants. While no single destruction method is mandated, regulations require that controlled substances be rendered non-retrievable.

Controlled substances are prescription medications and hazardous pharmaceuticals regulated by the DEA and categorized into schedules based on abuse potential.

Schedule V substances have the lowest abuse potential, while Schedule I substances have the highest risk of dependence. Regardless of classification, all controlled substances require compliant containment and disposal.

Several pharmaceuticals are regulated as both DEA-controlled substances and RCRA hazardous waste. Examples include chloral hydrate, fentanyl sublingual spray, phenobarbital, testosterone gels and solutions, and certain formulations of diazepam such as injectables and gels.

The EPA “Sewer Ban,” effective August 2019, prohibits healthcare facilities from disposing of hazardous waste pharmaceuticals down sinks or drains.

Water treatment systems are not designed to fully remove pharmaceutical compounds. Studies have documented pharmaceutical contamination in sewage, surface water, and groundwater systems. As a result, federal, state, and local authorities recommend against flushing medications. Since August 21, 2019, the EPA has prohibited healthcare facilities and reverse distributors from sewering hazardous waste pharmaceuticals. In addition to this prohibition, sewer disposal of pharmaceuticals is strongly discouraged except in very limited circumstances.

Yes. Tattoo shops generate sharps waste through the use of needles and other skin-penetrating instruments. While volumes are typically low, proper sharps disposal is still required to maintain compliance and safety. Many tattoo facilities choose disposal services based on their waste volume and service frequency needs.

Single-use sharps containers, once properly sealed, can typically be disposed of inside a corrugated cardboard box or approved container designated for regulated medical waste (red bag waste), in accordance with applicable regulations.

Para obtener más información y recursos sobre la eliminación segura de residuos punzocortantes, visite el sitio web de Sharps Medical Waste Services y consulte la sección de recursos disponible en español.

English Version: For more information and resources on the safe disposal of sharps waste, visit the Sharps Medical Waste Services website and explore the resources section available in Spanish.

Sharps waste is a category of biomedical waste made up of used devices that can puncture or cut the skin. Common examples include disposable scalpels and blades, hypodermic needles and lancets, broken capillary tubes, rigid broken plastic, and culture slides. All used sharps must be placed in an approved sharps disposal container to ensure safe handling and compliant disposal.

Sharps containers should never be overfilled. Once the fill line is reached, the container should be securely closed and prepared for collection according to your facility’s service schedule and regulatory requirements. Proper handling and timely removal of full sharps containers helps maintain workplace safety and supports compliance with state and federal regulations governing sharps waste management.

No. Many items listed as Hazardous Drugs (HDs) include chemotherapy medications. In bulk quantities (greater than 3%), these drugs must be disposed of as RCRA hazardous waste, while trace quantities (less than 3%) may be disposed of in an approved chemotherapy waste container. Personal protective equipment (PPE) used when handling hazardous drugs may contain trace contamination and should therefore be disposed of in a certified chemotherapy waste container rather than a red bag.

No. Disposable PPE must not be reused. All PPE worn while handling hazardous drugs is considered contaminated with at least trace quantities of those substances and must be placed in an appropriate USP 800–compatible waste container and disposed of according to local, state, and federal regulations. PPE worn during compounding should be discarded in the proper waste container before leaving the containment secondary engineering control (C-SEC) area.

Sharps Medical Waste Services supports compliant containment practices for sharps and soft waste categorized as USP 800 waste under the USP 800 standard. Facilities should follow approved containment and disposal practices aligned with regulatory requirements for hazardous drug waste streams.

No. Drug categorization itself does not change under USP 800. Environmental Protection Agency (EPA) regulations continue to apply to medications listed as hazardous, and existing pharmaceutical disposal procedures must still be followed. Packaging materials, such as wrappers that have come into contact with hazardous drugs, may be collected in approved trace chemotherapy containers where applicable.

Compliance involves following recommended procedures that promote safe hazardous drug handling in healthcare settings. This includes proper storage of hazardous drugs, use of appropriate personal protective equipment, eliminating reuse of disposable PPE when leaving hazardous drug handling areas, and ensuring contaminated materials are disposed of using approved waste containment methods in accordance with regulatory expectations.

All PPE used during the administration or handling of drugs listed under USP 800 must be disposed of in appropriate containment, such as trace chemotherapy or hazardous waste containers. Healthcare workers handling drugs that pose reproductive or other health risks must ensure PPE remains single-use and is replaced regularly to reduce cross-contamination risk.

No. USP 800 is a recommended standard for the safe handling of hazardous drugs. However, elements of compliance may be enforced through various regulatory and accreditation agencies at local, state, and federal levels depending on jurisdiction and oversight requirements.

The National Institute for Occupational Safety and Health (NIOSH) developed a list of hazardous drugs defined by characteristics such as carcinogenicity, developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or structural similarity to existing hazardous drugs. *USP 800 outlines safe handling practices for these NIOSH-listed hazardous drugs to reduce occupational exposure risks.

*https://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare

USP 800 applies to healthcare facilities that handle NIOSH-listed hazardous drugs, including hospitals, oncology centers, laboratories, pharmacies, and similar clinical environments where antineoplastic or other hazardous medications are stored, prepared, transported, or administered.

As the majority of USP 800 waste consists of the PPE used in the handling of hazardous drugs and such waste is contaminated by trace amounts of hazardous substances, the most cost-efficient means of compliant disposal is in a chemotherapy waste container. The alternative is over-classifying the waste as RCRA and disposing in a black bin; however, this will incur significant increases in cost of collection and disposal. Daniels’ reusable Chemosmart container is the safest and most environmentally efficient solution on the market for the collection of USP 800 waste.

USP Chapter 800 establishes a framework for developing procedures governing the safe handling of hazardous drugs within healthcare environments. The standard identifies hazardous drugs separately from traditional hazardous classifications and introduces guidance for handling, storage, and disposal of PPE, packaging, and materials exposed to these substances. Further information about USP800 can be found at www.usp.org

USP 800 took effect on December 1, 2019, following a delayed implementation period from its originally scheduled effective date.

The USP 800 standard applies to all healthcare personnel who handle hazardous drug (HD) preparations, as well as any facility that stores, prepares, transports, or administers hazardous drugs. This includes pharmacies, hospitals, outpatient clinics, physician practices, and veterinary offices. Personnel who may be exposed to hazardous drugs include pharmacists, pharmacy technicians, nurses, physicians, physician assistants, home healthcare workers, veterinarians, and veterinary technicians. All individuals and facilities involved in the handling of hazardous drugs must follow the requirements outlined in USP 800 to ensure safe practices and regulatory compliance.

Oversight of USP 800 varies by state, and enforcement can involve multiple agencies at the local, state, and federal levels. Accrediting bodies, such as The Joint Commission, also evaluate facilities for compliance with USP compounding standards, including the requirements outlined in USP 800.

USP 800 was developed to protect healthcare workers who handle hazardous drugs from occupational exposure risks, including reproductive and long-term health effects. The standard establishes consistent safety practices intended to reduce exposure and improve handling procedures across healthcare environments.

The FDA has clearly stated that methanol and 1-propanol are not acceptable active ingredients for hand sanitizer products and, due to their toxic effects, must not be used. Methanol can be toxic when absorbed through the skin and life-threatening when ingested. FDA investigations have found that hand sanitizer products containing these toxic alcohols are often incorrectly labelled, making it the responsibility of users to verify the safety and efficacy of the products they select and use.

In November 2020, the U.S. Department of Agriculture issued guidance regarding the management and disposal of hand sanitizer. The memorandum instructs that USDA agencies manage all hand sanitizer as a Class 3 Flammable Liquid in accordance with 29 CFR § 1910.106 and 1926.152.

Federal disposal guidelines require that all alcohol-based hand sanitizer products be treated as hazardous waste due to the ignitability characteristic (40 CFR § 261.21). As with all hazardous waste, disposal must be handled by a certified waste hauler permitted to transport and store hazardous materials in accordance with applicable regulations.

Federal and state regulations outline the required protocols for safely handling and disposing of regulated medical waste. These typically include DOT training and certification for any staff who package, handle, label, or sign manifests for RMW, regardless of which waste provider is used. Facilities must also provide HIPAA training to protect patient information, as well as Bloodborne Pathogens (BBP) training to ensure staff understand how to work safely around bloodborne pathogens, infectious diseases, and exposure risks.

Yes. The 64-Series containers are designed for hospital operating rooms and include an opening large enough to accommodate Da Vinci surgical arms and other large laparoscopic or sharps instruments.

Our sharps containers have been shown in multi-center peer-reviewed studies to reduce sharps injury incidence. The standard container design restricts hand entry to help prevent retrieval of discarded sharps.

A liquid seal fixed around the rim of the container lid helps eliminate leakage of bodily fluids during transport. Leakage is a known hazard in containers not equipped with leak-proof sealing systems.

In the United States, common healthcare waste color designations include red for regulated medical waste (RMW), biomedical, and pathological waste; yellow for trace chemotherapy waste; purple or blue for non-hazardous pharmaceutical waste; and black for hazardous waste.

Sharps containers are designed to function without wall cabinets to minimize wall space requirements and maximize container capacity. Our sharps containers come with a range of safety features depending on the model. Some include an anti-kickback lid, automatic shutoff to prevent overfilling, a bold red “FULL” indicator, and locking tabs for secure final closure. Others use a secure white lid with a restricted opening to prevent hand entry and a permanent-closure design that cannot be reopened once sealed. Additional models incorporate tamper-resistant, secure-access designs with locking mechanisms for public or semi-public areas, as well as locking lids that prevent accidental opening or retrieval of contents during handling or transport. Because these safety features are built directly into the container itself, external wall cabinets are unnecessary, allowing for safer, more efficient placement and easier access at the point of use.

U.S. safety guidance advises that needles should not be removed from syringes due to needlestick injury risk. For this reason, needle disconnect tools are not included as a container feature.

There is no bloodborne pathogen (BBP) risk associated with sharps containers themselves. BBP transmission occurs through stick, splash, or scratch exposure, not from clean environmental surfaces or aerosols.

It cannot be stated through published scientific evidence that reusable containers reduce patient-related HAIs. However, available information demonstrates that container design and processing support established HAI-reduction protocols and are not considered a source of infection transmission.

Medical device collection has been a common practice since the 1970s. Opening and closing container lids has not been documented as a source of pathogen or disease transmission, and no regulation requires lids to remain closed during procedures.

Container processing uses combined physical, chemical, and thermal methods verified through independent testing to exceed CDC decontamination requirements. Testing shows that these methods remove high-level pathogens, including tough organisms like C. difficile spores, at levels far beyond what is typically found in patient-care environments.

Foot-pedal opening mechanisms and bagless systems reduce hand contact with containers. Once full, containers are removed, emptied, and subjected to a multi-stage robotic wash and decontamination process achieving a validated bacterial load reduction.

Full and clean containers are not routinely stored together; however, if this occurs, no disease transmission risk has been identified.

There is no associated disease transmission risk to full and clean containers stored together.

No. CDC tuberculosis guidelines do not require procedural changes for sharps containers. Standard and transmission-based precautions remain sufficient.

No transmission of C. difficile via sharps containers has been reported in published literature. Studies show no significant difference between reusable and disposable container surfaces, and processing removes tested contamination.

Although prions are pieces of protein that are extremely hardy and cannot be killed by normal autoclaving, CDC guidance indicates prion transmission does not occur from environmental surfaces. Validation procedures confirm removal of blood and body fluids during processing, and reusable sharps containers have been used globally for decades without reported transmission incidents.

Safety-engineered devices help reduce injuries but are not sufficient on their own. Studies show many injuries occur when devices are not activated prior to disposal. Safe sharps container systems used alongside SEDs are essential for protecting staff and patient safety.

The Centers for Disease Control and Prevention (CDC) estimates that 62–88% of sharps injuries may be prevented through safer medical devices and improved sharps disposal systems.

An international study has shown that sharps containers are highly safe, with no reported cases of hand entry, retrieval of discarded sharps, or injuries caused by container penetration. Sharps containers are designed to remain open during use and only be closed when they are ready for disposal. Our patented design, combined with proper mounting heights, ensures that once sharps are dropped inside, they cannot be accessed again.

Recapping needles is considered unsafe and is discouraged under OSHA guidelines. If recapping is required for a specific procedure, approved methods such as a one-hand scoop technique or recapping device must be used before disposal in an approved sharps container.

A needlestick injury is a skin puncture caused by needles or other sharps and may occur during use, disassembly, or disposal. Disposal-related incidents remain one of the most common causes.

OSHA’s Bloodborne Pathogens Standard (29 CFR 1910.1030) requires employers to maintain a Sharps Injury Log that records all injuries involving contaminated sharps, including those related to sharps containers, to help evaluate devices and identify trends in risk.

As of 2022 in the United States, the average estimated cost of a single needlestick injury is approximately $4,352, excluding long-term treatment or litigation costs. Serious infection cases may exceed $1 million in associated expenses.

The Needlestick Safety and Prevention Act, enacted in November 2000, required OSHA to revise bloodborne pathogen standards to strengthen protections related to sharps injuries and safer medical devices. OSHA published its “Revision to OSHA’s Bloodborne Pathogens Standard, Technical Background and Summary, Needlestick Fact Sheet” (2001, May 9), which clearly outlines the updates to the standard. More information is available on OSHA’s Bloodborne Pathogens page: https://www.osha.gov/SLTC/bloodbornepathogens/index.html

Medical waste is dangerous because it can expose people to serious health risks. According to the World Health Organization (WHO), these risks include needlestick injuries, contact with bloodborne diseases such as hepatitis B, hepatitis C, and HIV, exposure to cytotoxic chemotherapy drugs, and exposure to harmful or drug-resistant microorganisms.

If you experience a needlestick injury, encourage the wound to bleed under running water, then wash it gently with soap and water without scrubbing. Don’t suck the wound. Dry the area, cover it with a waterproof dressing, and seek urgent medical evaluation right away.

Sharps Medical Waste Services offers a self-installation option for smaller to mid-sized customers. For additional information, please visit SharpsMWS.com or contact Sharps customer support at 888.784.3590.

Yes, a screwdriver may be used; however, this is not the recommended installation method, as installation is significantly easier when using a power drill.

Sharps provides educational resources covering the safe use of sharps, chemotherapy, and pharmaceutical waste containers, including guidance on proper waste segregation for compliant disposal. Please visit SharpsMWS.com or contact Sharps customer support at 888.784.3590 for available training and educational materials.

Each anchor will hold up to 50 lbs. If installing S32 containers on a wall, we recommend using 5 screws for locking brackets and at least 4 screws for standard brackets

If you are unable to complete the installation, Sharps Medical Waste Services can arrange for a trained field service representative to visit your facility and complete the installation. To request this service, please contact your Sharps setup representative. Installation fees may apply and are calculated based on time and travel distance.

If a wall stud is encountered while drilling, you will need to re-drill a new hole so that an anchor can be properly installed.

NIOSH recommendations suggest mounting a sharps container at approximately 48 inches to help reduce the risk of injury during use.

Sharps Medical Waste Services owns the Mailback/Shipback and TakeAway Recovery Systems sharps containers and supplies them to customers for use under a service-based model similar to a lease arrangement. SharpsMWS also owns the container molds and maintains multiple manufacturing locations and regional warehouse distribution to support continuity of supply.

Sharps Medical Waste Services safety-engineered containers are designed with multiple replaceable components to minimize waste across the product lifecycle. Individual components can be replaced if compromised, ensuring safety and functionality are maintained. Each container undergoes quality control inspection when returned to a processing facility. Critical components are tested and replaced if necessary.

At the end of their usable lifespan, containers are sent for recycling, where materials are processed and reintroduced into plastic manufacturing applications.

The Mailback/Shipback and TakeAway Recovery Systems sharps containers are certified for up to 500 uses and may remain in service for approximately 30–40 years, depending on usage conditions.

Mailback containers are designed for simple, single-action disposal in homes, small offices, and low-volume healthcare settings. Each system includes a sharps container and a prepaid return box, allowing users to safely package and ship their filled container for compliant destruction without needing pickup services.

TakeAway Recovery Systems are built for higher-volume or ongoing sharps disposal needs in clinics, pharmacies, workplaces, and medical facilities. These systems offer larger-capacity containers and often come in multi-unit kits. They provide secure, compliant disposal with prepaid return shipping, making them ideal for environments that require continuous access and frequent use.

All Sharps Medical Waste Services sharps containers are suitable for MRI environments except those that include metal components or wall-mounting hardware.

The Sharps containers are designed for operating room environments and features a large opening to support safe instrument disposal.

No. Once locks are engaged, the container must be returned to a Sharps Medical Waste Services processing facility. Reusable sharps containers must not be manually opened, emptied, or cleaned in a manner that exposes staff to injury risk.

When the container reaches maximum capacity, simply lock the container. Clear instructions have been provided on the containers.

Operating instructions are available through Sharps Medical Waste Services standard operating procedure resources at https://www.youtube.com/watch?v=MstquQ0YAjo.

Each sharps container color is aligned with a specific waste stream to support proper segregation and compliance. Red or ivory containers are typically used for sharps or regulated medical waste. Yellow containers are designated for trace chemotherapy or other cytotoxic waste. For information on Sharps Medical Waste Services’ available container options, visit https://store.sharpsinc.com/.

Full and clean containers are not routinely stored together; however, if this occurs, no disease transmission risk has been identified.

There is no associated disease transmission risk to full and clean containers stored together.

Yes. Sharps Medical Waste Services sharp containers are designed with a rear mounting system compatible with brackets, carts, and mobile units, allowing movement throughout facilities without floor contact.

Although not explicitly prohibited by regulation, floor placement increases risk to staff and the public and may result in compliance citations.

Storage duration depends on waste type and applicable state or local regulations. Please consult regulatory guidance applicable to your jurisdiction.

Reusable containers are designed for efficient capacity and typically require no more storage space than disposable alternatives. Storage needs vary based on delivery and collection frequency and facility requirements.

Please contact your Sharps Medical Waste Services account representative or customer support at [email protected].

No, but they require storage space comparable to disposable containers.

Please contact Sharps Medical Waste Services customer support at [email protected] for assistance.

In accordance with OSHA guidance, sharps containers must be easily accessible and located as close to areas where sharps are used or expected.

Internal distribution and exchange procedures depend on each facility’s protocols and resources. Exchanges may be completed by facility staff or arranged through Sharps Medical Waste Services as part of service agreements.

Sharps Medical Waste Services transports customer medical waste using company-operated vehicles driven by trained personnel. In some situations where partners are engaged to collect hazardous or general medical waste, a partner fleet may be responsible for pickup of medical waste and sharps disposal containers.

Purpose-built bulk delivery carts are engineered to enable efficient handling of reusable sharps disposal containers both within healthcare facilities and during transport. These transportation accessories help keep containers elevated from the ground to reduce cross-contamination risk, maintained upright, and properly spaced to prevent abrasions. While in transport, containers remain secured within vehicle housing to help prevent damage, contamination, or spillage.

Sharps Medical Waste Services operates medical waste processing facilities together with transfer stations that support efficient transportation of healthcare waste across its service network. Processing sites are equipped with robotic washline technology for reusable container processing and treatment technology used to treat sharps, medical waste, chemotherapy waste, hazardous waste, and pharmaceutical waste.

Sharps Medical Waste Services maintains a large-scale servicing infrastructure supporting healthcare facilities across its operating regions.

Processing facilities and transfer stations are located throughout service regions to support efficient coverage. Please visit the Sharps Medical Waste Services website or contact page for additional location information.

Processing locations are monitored using high-quality security camera systems. Security is further supported through staff education, training, and ongoing monitoring of operational activities. Medical waste transport vehicles are also equipped with GPS tracking technology.

Our processing facilities are equipped with advanced treatment technologies designed to ensure safe, efficient, and compliant medical waste management. Central to our operations are high-capacity, full-vacuum steam autoclaves capable of processing multiple large carts per cycle. These systems utilize pressurized steam generated by natural gas–powered boilers to effectively treat regulated medical waste and sharps containers.

In addition to steam sterilization, we employ a range of complementary technologies to support specialized waste streams and sustainability initiatives. These include pyrolysis systems for material reduction, ozone-based treatment for enhanced disinfection, and thermal processes engineered to optimize waste volume reduction and resource recovery.

We also support single-use device reclamation programs, helping healthcare providers reduce waste and recover value from select materials. Our integrated approach prioritizes safety, environmental responsibility, and regulatory compliance across all operations.

Sharps container reprocessing systems are engineered for continuous performance, safety, and regulatory compliance. Our infrastructure combines automated cleaning technology with routine preventative maintenance performed by certified technicians to ensure consistent, high-quality outcomes.

Each year, our facilities safely process millions of reusable sharps containers across a nationwide network of service centers. Every unit undergoes a multi-step decontamination cycle designed to eliminate contaminants, reduce handling risks, and extend container lifespan.

Our operations meet or exceed all applicable federal, state, and local standards, with rigorous quality controls built into every stage of the process. Through ongoing system monitoring, equipment validation, and staff training, we deliver a reliable, closed-loop solution that prioritizes safety, efficiency, and environmental responsibility.

Sharps Medical Waste Services offers confidential document destruction in select service areas. Please contact our Sharps support team by emailing at [email protected] to confirm services in your local area.

Sharps Medical Waste Services transports customer medical waste using its own fleet of vehicles operated by trained service professionals. In certain situations, approved service partners may be engaged to support the collection of specific hazardous or mGeneraledical waste streams, depending on operational requirements and location.

Sharps Medical Waste Services supports organizations of all sizes, from small independent practices with lower waste volumes and flexible pickup needs, including veterinary clinics, surgical centers, and long-term care facilities, to large laboratories, universities, and multi-campus healthcare systems. We have medical waste and sharps disposal containers designed to accommodate the full range of healthcare waste streams generated by these facilities, including regulated medical waste, sharps waste, pharmaceutical waste, chemotherapy waste, and hazardous waste.

Sharps Medical Waste Services manages a wide range of healthcare waste streams generated by medical and commercial facilities, including regulated medical waste, sharps waste, pharmaceutical waste, chemotherapy waste, controlled substance deactivation, and RCRA hazardous waste and hazardous chemicals. In addition, Sharps also delivers comprehensive waste management services to hospitals nationwide, supported by dedicated divisions for Secure Document Destruction and Total Waste Management. Through these teams, we manage document shredding, solid waste and recycling, e-waste, and universal waste.

You can order a new return shipping box directly from Sharps Medical Waste Services. Each new box comes with a prepaid postage shipping label included, so you’re ready to ship as soon as it arrives.

Your sharps container must be shipped inside a DOT-certified return shipping box that is approved for mailing through the U.S. Postal Service. Using an uncertified box does not meet federal shipping requirements for medical waste. Order a replacement return box through Sharps Medical Waste Services to ensure your shipment is fully compliant.

Return shipping labels do not expire. If your container is still within its fill capacity and undamaged, you can use the existing label to ship it back for treatment. If you have any concerns about the condition of an older system, contact our support team before mailing.

The customer portal is currently a one-to-one platform, meaning each account corresponds to a single location. Customers managing multiple locations will need a separate login for each. We understand this is an inconvenience and are continuously working to improve the portal experience. For assistance managing multiple accounts, contact our support team directly.

You have several options for safe, compliant disposal:

• Purchase a return shipping label from Sharps Medical Waste Services to mail your container back for treatment
• Find a local drop-off location near you at safeneedledisposal.org
• Contact your local Health Department, Fire Department, or Police Station — many offer sharps drop-off programs at no cost
• Contact your local municipal waste disposal company for guidance on how to package your container for curbside pickup in your area

You have two easy options:

• Log into your SharpsTracer account to view your full pickup schedule online
• Contact our support team by emailing [email protected] or calling 800-772-5657

Experts in the regulatory complexities governing the healthcare sector, we position ourselves as a knowledgeable partner delivering guidance and compliant solutions to customers. All compliance and education solutions are vetted against applicable state and federal regulations and executed through waste plans and training to support optimized safety and compliance. Sharps Medical Waste Services offers face-to-face training as well as a user-friendly online compliance training portal.

HIPAA applies to all healthcare providers including medical spas, laser centers, cosmetic surgery, and aesthetic practices (effectively anyone involved with creating or maintaining patients’ healthcare records).

Approximately 5% of the average drug inventory is considered hazardous waste by the EPA. These drugs must be handled, managed, transported, and disposed of as hazardous waste and should always be placed in an approved hazardous waste container. The Pharmaceutical Characterization Portal provides the tools necessary for facilities to maintain compliance with EPA and DOT requirements. Each time users log into the online portal, the current inventory database is re-evaluated to provide the most up-to-date hazardous waste classification information available.

The SDS/MSDS database contains over one million safety data sheets, updated weekly. Data sheets can be stored online, printed for binder or location use, or downloaded for offline access.

The portal promotes versatile learning across multiple platforms and serves as a centralized resource that provides self-paced targeted learning for staff, a management dashboard to assess staff competency, online records for employee training, unlimited audits and safety plans, printable certificates, employee audit dashboards with corrective action assignment tools, and library access to millions of MSDS documents and federal regulations updated weekly.

Facilities must comply with the Occupational Health and Safety Act, the Resource Conservation and Recovery Act, and the Code of Federal Regulations, in addition to applicable state laws, to maintain OSHA compliance.

Sharps Medical Waste Services offers DOT: Regulated Medical Waste, HIPAA, BBP, and GHS/HazCom training through the online compliance portal. The platform enables staff to complete certification through online training, maintain learning records, access certifications, and use a centralized regulations library within a single system.

Healthcare workers who are exposed or potentially exposed to hazardous waste are required to receive training on Bloodborne Pathogens (for Healthcare), GHS HazCom, and HIPAA, HITECH & OMNIBUS.

Our general medical waste education includes face-to-face training across all shifts, personal in-servicing at the individual unit level, posters and printed materials to reinforce correct behavior at the point of disposal, and self-paced eLearning modules.

Machine operator roles may be available depending on location and operational needs. Please visit Careers to view current openings in your area.

Visit Careers and use the location filter to search for opportunities near you.

Please refer to the requirements listed in each job posting. Some roles may require a degree, while others prioritize relevant skills and experience. All experience is meaningful and valued here!

Yes. Applicants must be 18 years of age or older to be eligible for employment.

Most customer service opportunities are based within support offices or local operating locations. Available roles can be viewed at Careers.

Sharps Medical Waste Services operates out of the United States only. Available roles are listed on the careers page. Please visit Careers to view current openings and opportunities.

Sharps Medical Waste Services does not offer delivery-only roles. Driver positions may include additional operational responsibilities. To learn more or view open roles, visit Careers.

Forklift operator roles are not typically standalone positions. However, loader and unloader roles may be available where related skills and certifications are transferable. Please review current opportunities at Careers.

Sharps Medical Waste Services is an equal opportunity employer. Visa sponsorship is not standard practice.

If you would like to explore the types of roles we typically hire for, such as drivers, sales professionals, and field service positions, please visit Careers to review job descriptions and hear from members of our team. To explore all current role types and responsibilities, visit Careers, where you can access detailed job descriptions and view all available openings.

Driver candidates require a minimum of six months of driving experience to meet compliance requirements.

We recommend reviewing the information available on SharpsMWS.com, including the About Us and our Why Sharps Medical Waste Services, to learn more about who we are and what we do.

If an application link is not provided, please visit Careers and follow the prompts to locate and apply for the role.

Recruitment timelines vary depending on the stage of hiring and application volume. Our recruiting team reviews applications as quickly as possible. If you have questions, please contact [email protected].

Certification requirements vary by role. Some positions may include training support, while others require specific licenses. Please contact [email protected] for guidance.

You may resend your application materials if needed or contact [email protected] for assistance.

Field service roles are based within healthcare facilities and involve moving sharps and medical waste containers throughout a facility and exchanging full containers for empty ones at the department level. These positions are customer-facing and suited for individuals who enjoy supporting healthcare environments. To learn more, visit Careers or contact [email protected].

Compensation varies based on market conditions, skills, experience, and location. For additional information, please contact [email protected].

If you would like to learn more about a specific business unit, please visit About Us or view the location’s Google Business Profile by searching “Sharps Medical Waste Services location of interest” on Google. If you are interested in career opportunities with Sharps Medical Waste Services, please visit Careers or contact us at [email protected].